Logo image of ALLIX.PA

WALLIX GROUP (ALLIX.PA) Stock Fundamental Analysis

Europe - EPA:ALLIX - FR0010131409 - Common Stock

23.2 EUR
-0.55 (-2.32%)
Last: 11/19/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, ALLIX scores 2 out of 10 in our fundamental rating. ALLIX was compared to 107 industry peers in the Software industry. ALLIX may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ALLIX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ALLIX has reported negative net income.
ALLIX had a positive operating cash flow in the past year.
In the past 5 years ALLIX always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: ALLIX reported negative operating cash flow in multiple years.
ALLIX.PA Yearly Net Income VS EBIT VS OCF VS FCFALLIX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

Looking at the Return On Assets, with a value of -3.53%, ALLIX is doing worse than 65.42% of the companies in the same industry.
Looking at the Return On Equity, with a value of -24.56%, ALLIX is doing worse than 75.70% of the companies in the same industry.
Industry RankSector Rank
ROA -3.53%
ROE -24.56%
ROIC N/A
ROA(3y)-11.47%
ROA(5y)-10.77%
ROE(3y)-44.92%
ROE(5y)-35.34%
ROIC(3y)N/A
ROIC(5y)N/A
ALLIX.PA Yearly ROA, ROE, ROICALLIX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

Looking at the Gross Margin, with a value of 108.52%, ALLIX belongs to the top of the industry, outperforming 98.13% of the companies in the same industry.
ALLIX's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ALLIX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 108.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.14%
GM growth 5Y-0.06%
ALLIX.PA Yearly Profit, Operating, Gross MarginsALLIX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100

0

2. Health

2.1 Basic Checks

ALLIX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The debt/assets ratio for ALLIX has been reduced compared to a year ago.
ALLIX.PA Yearly Shares OutstandingALLIX.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
ALLIX.PA Yearly Total Debt VS Total AssetsALLIX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of 1.30, we must say that ALLIX is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.30, ALLIX is doing worse than 69.16% of the companies in the same industry.
A Debt/Equity ratio of 1.07 is on the high side and indicates that ALLIX has dependencies on debt financing.
ALLIX's Debt to Equity ratio of 1.07 is on the low side compared to the rest of the industry. ALLIX is outperformed by 82.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF N/A
Altman-Z 1.3
ROIC/WACCN/A
WACC8.41%
ALLIX.PA Yearly LT Debt VS Equity VS FCFALLIX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 0.79 indicates that ALLIX may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.79, ALLIX is doing worse than 81.31% of the companies in the same industry.
A Quick Ratio of 0.79 indicates that ALLIX may have some problems paying its short term obligations.
ALLIX has a worse Quick ratio (0.79) than 80.37% of its industry peers.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.79
ALLIX.PA Yearly Current Assets VS Current LiabilitesALLIX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

6

3. Growth

3.1 Past

ALLIX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.11%, which is quite impressive.
Looking at the last year, ALLIX shows a quite strong growth in Revenue. The Revenue has grown by 17.72% in the last year.
Measured over the past years, ALLIX shows a quite strong growth in Revenue. The Revenue has been growing by 15.85% on average per year.
EPS 1Y (TTM)79.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.98%
Revenue 1Y (TTM)17.72%
Revenue growth 3Y13.73%
Revenue growth 5Y15.85%
Sales Q2Q%18.89%

3.2 Future

The Earnings Per Share is expected to grow by 63.74% on average over the next years. This is a very strong growth
ALLIX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.11% yearly.
EPS Next Y103.9%
EPS Next 2Y75.81%
EPS Next 3Y63.74%
EPS Next 5YN/A
Revenue Next Year20.41%
Revenue Next 2Y21.78%
Revenue Next 3Y22.11%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALLIX.PA Yearly Revenue VS EstimatesALLIX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ALLIX.PA Yearly EPS VS EstimatesALLIX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1

3

4. Valuation

4.1 Price/Earnings Ratio

ALLIX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
ALLIX is valuated quite expensively with a Price/Forward Earnings ratio of 26.81.
The rest of the industry has a similar Price/Forward Earnings ratio as ALLIX.
When comparing the Price/Forward Earnings ratio of ALLIX to the average of the S&P500 Index (35.39), we can say ALLIX is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 26.81
ALLIX.PA Price Earnings VS Forward Price EarningsALLIX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60 -80

4.2 Price Multiples

ALLIX's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ALLIX is more expensive than 63.55% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 50.08
ALLIX.PA Per share dataALLIX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALLIX's earnings are expected to grow with 63.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y75.81%
EPS Next 3Y63.74%

0

5. Dividend

5.1 Amount

No dividends for ALLIX!.
Industry RankSector Rank
Dividend Yield N/A

WALLIX GROUP

EPA:ALLIX (11/19/2025, 7:00:00 PM)

23.2

-0.55 (-2.32%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-09 2025-10-09
Earnings (Next)03-18 2026-03-18/amc
Inst Owners12.33%
Inst Owner ChangeN/A
Ins Owners19.92%
Ins Owner ChangeN/A
Market Cap154.98M
Revenue(TTM)36.95M
Net Income(TTM)-1.80M
Analysts84
Price Target31.11 (34.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)35.56%
PT rev (3m)35.56%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-50%
EPS NY rev (3m)-50%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.2%
Revenue NY rev (3m)-1.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 26.81
P/S 4.19
P/FCF N/A
P/OCF 37.52
P/B 19.37
P/tB N/A
EV/EBITDA 50.08
EPS(TTM)-0.28
EYN/A
EPS(NY)0.87
Fwd EY3.73%
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)0.62
OCFY2.66%
SpS5.53
BVpS1.2
TBVpS-1.83
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.53%
ROE -24.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 108.52%
FCFM N/A
ROA(3y)-11.47%
ROA(5y)-10.77%
ROE(3y)-44.92%
ROE(5y)-35.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.14%
GM growth 5Y-0.06%
F-Score5
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF N/A
Debt/EBITDA 2.35
Cap/Depr 121.43%
Cap/Sales 18.86%
Interest Coverage N/A
Cash Conversion 124.02%
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.79
Altman-Z 1.3
F-Score5
WACC8.41%
ROIC/WACCN/A
Cap/Depr(3y)134.6%
Cap/Depr(5y)153.57%
Cap/Sales(3y)19.1%
Cap/Sales(5y)22.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.98%
EPS Next Y103.9%
EPS Next 2Y75.81%
EPS Next 3Y63.74%
EPS Next 5YN/A
Revenue 1Y (TTM)17.72%
Revenue growth 3Y13.73%
Revenue growth 5Y15.85%
Sales Q2Q%18.89%
Revenue Next Year20.41%
Revenue Next 2Y21.78%
Revenue Next 3Y22.11%
Revenue Next 5YN/A
EBIT growth 1Y75.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year122.61%
EBIT Next 3Y63%
EBIT Next 5YN/A
FCF growth 1Y50.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y548.91%
OCF growth 3Y-37.14%
OCF growth 5YN/A

WALLIX GROUP / ALLIX.PA FAQ

What is the ChartMill fundamental rating of WALLIX GROUP (ALLIX.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALLIX.PA.


Can you provide the valuation status for WALLIX GROUP?

ChartMill assigns a valuation rating of 3 / 10 to WALLIX GROUP (ALLIX.PA). This can be considered as Overvalued.


What is the profitability of ALLIX stock?

WALLIX GROUP (ALLIX.PA) has a profitability rating of 2 / 10.